REFERENCES
- Pharo G H, Zhou L. Pharmacologic management of cancer pain. J Am Osteopath Assoc 2005; 105(11 Suppl 5)S21–S28
- Gershell L, Goater J J. Making gains in pain. Nat Rev Drug Discovery 2006; 5: 889–890
- Bernabei R, Gambassi G, Lapane K, , Management of pain in elderly patients with cancer. SAGE Study Group, et al. Systematic assessment of geriatric drug use via epidemiology. JAMA 1998; 279: 1877–1882
- Choi Y S, Billings J A. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage 2002; 24: 71–90
- Thorpe D M. Management of opioid-induced constipation. Curr Pain Headache Rep 2001; 5: 237–240
- Portenoy R K. Management of common opioid side effects during long-term therapy of cancer pain. Ann Acad Med Singapore 1994; 23: 160–170
- Moore R A, McQuay H J. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomized trials of oral opioids. Arthritis Res Ther 2005; 7: R1046–R1051
- Staats P S, Markowitz J, Schein J. Prevalence of constipation associated with long-acting opioid therapy: a comparative study. South Med J 2004; 97: 129–134
- Charlson M E, Pompei P, Ales K L, McKenzie C R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383
- Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983; 78: 605–610
- Buntin M B, Zaslavsky A M. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ 2004; 23: 525–542
- Dennison C, Prasad M, Lloyd A, Bhattacharyya S K, Dhawan R, Coyne K. The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005; 23: 461–476
- Martin B C, Barghout V, Cerulli A. Direct medical costs of constipation in the United States. Manag Care Interface 2006; 19: 43–49
- Singh G, Lingala V, Wang H, et al. Use of health care resources and cost of care for adults with constipation. Clin Gastroenterol Hepatol 2007; 5: 1053–1058
- Bloodworth D. Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations. Phys Med Rehabil Clin N Am 2006; 17: 355–379
- Nicholson B, Passik S D. Management of chronic noncancer pain in the primary care setting. South Med J 2007; 100: 1028–1036
- Indelicato R A, Portenoy R K. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 2002; 20: 348–352
- Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004, (3):CD004847
- Ross J R, Riley J, Quigley C, Welsh K I. Clinical pharmacology and pharmacotherapy of opioid switching in cancer patients. Oncologist 2006; 11: 765–773
- Berger A, Hoffman D L, Goodman S, Delea T E, Seifeldin R, Oster G. Therapy switching in patients receiving long-acting opioids. Ann Pharmacother 2004; 38: 389–395
- Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev 2006; 32: 304–315
- Mancini I, Bruera E. Constipation in advanced cancer patients. Support Care Cancer 1998; 6: 356–364
- Losina E, Barrett J, Baron J A, Katz J N. Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003; 56: 515–519
- Newcomer R, Clay T, Luxenberg J S, Miller R H. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc 1999; 47: 215–219